5 Things to Know About Cannabidivarin (CBDV)
1. CBDV is a rare cannabinoid
Unlike well-known cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) which are abundant in the Cannabis plant, CBDV is known as a rare, or minor, cannabinoid and is typically found in miniscule quantities in non-modified strains of the plant.
2. CBDV is non-intoxicating
CBDV is a non-intoxicating rare cannabinoid. In addition, CBDV demonstrated a good safety profile in human clinical trials, with no adverse side effects reported even at the highest doses tested.
3. CBDV interacts with many cannabinoid receptors
Scientific literature suggests that CBDV acts as an agonist of TRPA1, TRPV1 and TRPV2 receptors, an inverse agonist of GPR6, an antagonist of GPR55 and may be an inhibitor of endocannabinoid 2-AG production.
4. CBDV is one of the most researched rare cannabinoids
CBDV has been researched for its potential anti-inflammatory, anti-convulsant and neurological effects and has been the subject of studies in autism, epilepsy, acne, alopecia, inflammatory bowel disease, nausea, and pain.
5. CBDV is being studied in clinical trials
Currently, there is no regulatory approval of CBDV for the therapeutic use for any condition, but it’s being studied in human clinical trials for a number of potential therapeutic uses such as autism, alopecia, Prader-Willi Syndrome and attention deficit hyperactive disorder (ADHD).
Interested in learning about the scientific research into the potential therapeutic effects of CBDV? You can sign up to download a copy BayMedica’s CBDV white paper here.
BayMedica has commenced B2B sales of CBDV, which is available wholesale as a raw ingredient for a variety of consumer health and wellness products, such as cosmetics, nutraceuticals, supplements and animal health. You can initiate an inquiry by emailing [email protected].